World's Best Scientists 2026 revealed!
Award Badge
Microbiology
USA
2026

D-Index & Metrics

Microbiology

D-Index
116
Citations
62304
World Ranking
177
National Ranking
82

Medicine

D-Index
117
Citations
62511
World Ranking
4146
National Ranking
2271

Robert A. Bonomo publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Robert A. Bonomo sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 709 publications — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Robert A. Bonomo D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Robert A. Bonomo sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 116 D-Index — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Microbiology in United States Leader Award
  • 2025 - Research.com Microbiology in United States Leader Award

Overview

Robert A. Bonomo is affiliated with Case Western Reserve University in the United States. Their research spans several key areas within biochemistry, genetics, molecular biology, and medicine, with a particular focus on molecular medicine, epidemiology, pharmacology, molecular biology, and endocrinology.

The scientist's work covers a spectrum of topics related to bacterial infections and antibiotic resistance. Major areas of research include:

  • Antibiotic Resistance in Bacteria
  • Antibiotics Pharmacokinetics and Efficacy
  • Antibiotic Use and Resistance
  • Vibrio bacteria research studies
  • Bacterial biofilms and quorum sensing
  • Pneumonia and Respiratory Infections
  • Tuberculosis Research and Epidemiology

Frequent publication venues where their work appears include:

  • Antimicrobial Agents and Chemotherapy
  • Open Forum Infectious Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Infectious Diseases
  • mBio

Robert A. Bonomo has co-authored extensively, collaborating most often with the following researchers:

  • David van Duin
  • Christopher R. Bethel
  • Andrea M. Hujer
  • María Soledad Ramírez
  • Alejandro J. Vila

Among their recent scientific papers are the following publications:

  • European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European Society of Intensive Care Medicine), 2021, Clinical Microbiology and Infection
  • Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections, 2023, Clinical Infectious Diseases
  • Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections, 2021, Clinical Infectious Diseases
  • Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa), 2022, Clinical Infectious Diseases
  • Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa), 2020, Clinical Infectious Diseases

The scientist's profile demonstrates a multidisciplinary approach to infectious diseases, addressing challenges related to antimicrobial resistance in Gram-negative bacteria through extensive clinical guidance and epidemiological research. The focus on bacterial pathogens such as Acinetobacter baumannii, Stenotrophomonas maltophilia, and Pseudomonas aeruginosa highlights a commitment to understanding and combating difficult-to-treat infections.

Best Publications

  • Extended-spectrum beta-lactamases: a clinical update.

    David L. Paterson;Robert A. Bonomo

  • Three Decades of β-Lactamase Inhibitors

    Sarah M. Drawz;Robert A. Bonomo;Robert A. Bonomo

  • Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases

    L Silvia Munoz-Price;L Silvia Munoz-Price;Laurent Poirel;Robert A Bonomo;Robert A Bonomo;Mitchell J Schwaber

  • Carbapenems: Past, Present, and Future

    Krisztina M. Papp-Wallace;Andrea Endimiani;Andrea Endimiani;Andrea Endimiani;Magdalena A. Taracila;Robert A. Bonomo

  • Global Challenge of Multidrug-Resistant Acinetobacter baumannii

    Federico Perez;Andrea M. Hujer;Kristine M. Hujer;Brooke K. Decker

  • Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

    Darren Wong;Travis B. Nielsen;Robert A. Bonomo;Paul Pantapalangkoor

  • Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas aeruginosa

    Robert A. Bonomo;Dora Szabo

  • International Prospective Study of Klebsiella pneumoniae Bacteremia: Implications of Extended-Spectrum β-Lactamase Production in Nosocomial Infections

    David L. Paterson;Wen Chien Ko;Anne Von Gottberg;Sunlta Mohapatra

  • 10 × '20 Progress—Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America

    Helen W. Boucher;George H. Talbot;Daniel K. Benjamin;Daniel K. Benjamin;John Bradley;John Bradley

  • Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients.

    Curtis J. Donskey;Tanvir K. Chowdhry;Michelle T. Hecker;Claudia K. Hoyen

  • Antibiotic Therapy for Klebsiella pneumoniae Bacteremia: Implications of Production of Extended-Spectrum β-Lactamases

    David L. Paterson;David L. Paterson;Wen Chien Ko;Anne Von Gottberg;Sunita Mohapatra

  • Outcome of Cephalosporin Treatment for Serious Infections Due to Apparently Susceptible Organisms Producing Extended-Spectrum β-Lactamases: Implications for the Clinical Microbiology Laboratory

    David L. Paterson;David L. Paterson;Wen-Chien Ko;Anne Von Gottberg;Jose Maria Casellas

  • Better tests, better care: improved diagnostics for infectious diseases.

    Angela M. Caliendo;David N. Gilbert;David N. Gilbert;Christine C. Ginocchio;Kimberly E. Hanson

  • Carbapenemase-Producing Organisms: A Global Scourge

    Robert A Bonomo;Robert A Bonomo;Eileen M Burd;John Conly;Brandi M Limbago

  • Analysis of Antibiotic Resistance Genes in Multidrug-Resistant Acinetobacter sp. Isolates from Military and Civilian Patients Treated at the Walter Reed Army Medical Center

    Kristine M. Hujer;Andrea M. Hujer;Edward A. Hulten;Saralee Bajaksouzian

  • Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae

    David Van Duin;Judith J. Lok;Michelle Earley;Eric Cober

  • Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding

    Liang Chen;Barun Mathema;Kalyan D. Chavda;Frank R. DeLeo

  • Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

    Belén Gutiérrez-Gutiérrez;Elena Salamanca;Marina de Cueto;Po-Ren Hsueh

  • Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations.

    David van Duin;Robert A. Bonomo

  • Comparative Genome Sequence Analysis of Multidrug-Resistant Acinetobacter baumannii

    Mark D. Adams;Karrie Goglin;Neil Molyneaux;Kristine M. Hujer

  • Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system

    Mark D. Adams;Gabrielle C. Nickel;Saralee Bajaksouzian;Heather Lavender

  • Extended-Spectrum β-Lactamases in Klebsiella pneumoniae Bloodstream Isolates from Seven Countries: Dominance and Widespread Prevalence of SHV- and CTX-M-Type β-Lactamases

    David L. Paterson;Kristine M. Hujer;Andrea M. Hujer;Bethany Yeiser

Frequent Co-Authors

Andrea M. Hujer
Andrea M. Hujer United States Department of Veterans Affairs
Federico Perez
Federico Perez Case Western Reserve University
Kristine M. Hujer
Kristine M. Hujer Case Western Reserve University
Michael R. Jacobs
Michael R. Jacobs University Hospitals of Cleveland
Barry N. Kreiswirth
Barry N. Kreiswirth Center for Discovery and Innovation
Krisztina M. Papp-Wallace
Krisztina M. Papp-Wallace Case Western Reserve University
Andrea Endimiani
Andrea Endimiani University of Bern
David L. Paterson
David L. Paterson University of Queensland
Liang Chen
Liang Chen Hackensack Meridian Health Center for Discovery and Innovation
Vance G. Fowler
Vance G. Fowler Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees related to Microbiology opens up diverse career options in healthcare, research, and technology. For instance, becoming a Child Life Specialist requires specialized training and certification, such as obtaining a ccls certification, which complements microbiology knowledge in pediatrics and patient care settings.

Those with a criminal background can also pursue stable educational paths. Resources like college degrees for felons highlight accessible programs that support career growth despite past challenges, making microbiology-related fields more attainable to a wider audience.

Healthcare professionals aiming to expand their scope might consider roles such as a Functional Medicine Nurse Practitioner, where understanding pathogens and the human microbiome can be critical. The functional medicine np salary reflects the growing demand in this innovative healthcare field.

Additionally, skills in medical coding and billing are essential to healthcare operations. Pursuing a credential like certified professional coder (cpc) can lead to rewarding positions that combine analytical expertise with healthcare knowledge.

Best Scientists Citing Robert A. Bonomo

Trending Scientists

Recently Published Articles